We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$29.7B
AUM Growth
+$1.97B
Cap. Flow
+$1.27B
Cap. Flow %
4.28%
Top 10 Hldgs %
54.74%
Holding
2,185
New
207
Increased
867
Reduced
691
Closed
168

Sector Composition

Rank Sector Weight
1 Financials 4.86%
2 Technology 4.06%
3 Healthcare 2.07%
4 Industrials 1.87%
5 Consumer Discretionary 1.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CXT icon
526
Crane NXT
CXT
$3.04B
$1.84M 0.01%
63,658
-811
-1% -$23.6K
RDHL
527
Redhill Biopharma
RDHL
$3.85M
$1.84M 0.01%
283
TTD icon
528
Trade Desk
TTD
$8.13B
$1.83M 0.01%
80,560
-3,280
-4% -$70.5K
STXB
529
DELISTED
Spirit of Texas Bancshares, Inc. Common Stock
STXB
$1.83M 0.01%
81,278
-11,901
-13% -$263K
SCHD icon
530
Schwab US Dividend Equity ETF
SCHD
$102B
$1.82M 0.01%
103,026
+12,039
+13% +$212K
LNT icon
531
Alliant Energy
LNT
$19.4B
$1.82M 0.01%
37,057
-1,978
-5% -$94.3K
NVO
532
Novo Nordisk
NVO
$216B
$1.81M 0.01%
70,758
+17,480
+33% +$432K
EVV
533
Eaton Vance Limited Duration Income Fund
EVV
$1.06B
$1.8M 0.01%
142,725
+27,725
+24% +$350K
DFS
534
DELISTED
Discover Financial Services
DFS
$1.8M 0.01%
23,237
+494
+2% +$38.3K
MPT
535
Medical Properties Trust
MPT
$2.89B
$1.8M 0.01%
103,089
+71,675
+228% +$1.29M
SHY icon
536
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$1.8M 0.01%
21,188
+3,953
+23% +$333K
SGOL icon
537
abrdn Physical Gold Shares ETF
SGOL
$6.92B
$1.79M 0.01%
131,510
+2,970
+2% +$37.5K
HPE icon
538
Hewlett Packard
HPE
$63.2B
$1.78M 0.01%
119,027
+978
+0.8% +$14.8K
VIS icon
539
Vanguard Industrials ETF
VIS
$8.23B
$1.77M 0.01%
12,177
+1,454
+14% +$207K
KN icon
540
Knowles
KN
$3.22B
$1.77M 0.01%
96,873
-3,867
-4% -$68.2K
PAYC icon
541
Paycom
PAYC
$6.78B
$1.77M 0.01%
7,788
-796
-9% -$163K
QLD icon
542
ProShares Ultra QQQ
QLD
$12.5B
$1.77M 0.01%
147,120
-1,120
-0.8% -$13.1K
AZN icon
543
AstraZeneca
AZN
$263B
$1.76M 0.01%
21,378
+40
+0.2% +$3.14K
USMV icon
544
iShares MSCI USA Min Vol Factor ETF
USMV
$23.2B
$1.74M 0.01%
28,194
-1,090
-4% -$65.4K
ROST icon
545
Ross Stores
ROST
$76.6B
$1.73M 0.01%
17,411
+2,139
+14% +$208K
VXUS icon
546
Vanguard Total International Stock ETF
VXUS
$153B
$1.71M 0.01%
32,475
+1,207
+4% +$63.1K
CAG icon
547
Conagra Brands
CAG
$7.07B
$1.7M 0.01%
64,208
-4,913
-7% -$143K
TEVA icon
548
Teva Pharmaceuticals
TEVA
$35.9B
$1.7M 0.01%
184,442
+65,642
+55% +$792K
VIAB
549
DELISTED
Viacom Inc. Class B
VIAB
$1.7M 0.01%
56,973
-959
-2% -$28K
MET icon
550
MetLife
MET
$61B
$1.7M 0.01%
34,212
-1,740
-5% -$81.8K

Similar funds

Creative Planning's Q2 2019 Portfolio in Review

As of Q2 2019, Creative Planning held 2,185 positions worth $29.7B, up 7.1% from $27.8B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Creative Planning deployed $1.27B of net new capital in Q2 2019, opening 207 new positions and adding to 867 existing holdings. Its largest new stake was Dow Inc: 108,999 shares worth $5.38M.

By sector, the portfolio is most concentrated in Financials at 4.9% of assets, up from 4.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Mid-Cap ETF, an estimated $115M trimmed.

  • Creative Planning's largest Q2 2019 buy was Dow Inc: 108,999 shares worth $5.38M.
  • Creative Planning added most to iShares Core US Aggregate Bond ETF in Q2 2019, an estimated $297M increase.
  • Creative Planning's biggest Q2 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $115M.
  • Creative Planning fully exited Intercept Pharmaceuticals, Inc. in Q2 2019, selling an estimated $3.71M.
  • Creative Planning's ten largest holdings make up 55% of its $29.7B portfolio in Q2 2019.
  • Creative Planning opened 207 new positions and closed 168 in Q2 2019.
  • Creative Planning's portfolio value rose 7.1% quarter-over-quarter to $29.7B.

Based on Creative Planning's 13F filing for Q2 2019, filed 26 Jul 2019.